Propyliodone

CHEMBL1200821 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
447.0 g/mol
LogP
2.4
Phase
4

Propyliodone is an iodinated oil contrast medium formerly used for bronchography to delineate the bronchial tree radiographically by filling the airways with a radiopaque iodine-containing compound. It has largely been replaced by modern CT bronchography and other imaging modalities, but was valuable for the diagnosis of bronchial and pulmonary diseases in the mid-20th century.

Peso molecular

447,0100 g/mol

LogP

2,40

TPSA

46,60 Ų

Regla de cinco de Lipinski

Cumple

Mecanismo de acción

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCOC(=O)Cn1cc(I)c(=O)c(I)c1

InChI

InChI=1S/C10H11I2NO3/c1-2-3-16-9(14)6-13-4-7(11)10(15)8(12)5-13/h4-5H,2-3,6H2,1H3

Molecular Formula

C10H11I2NO3

HBD / HBA

- / 4

Enlaces Rotables

5

Átomos Pesados

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

Propyliodone is an iodinated oil contrast medium formerly used for bronchography to delineate the bronchial tree radiographically by filling the airways with a radiopaque iodine-containing compound. It has largely been replaced by modern CT bronchography and other imaging modalities, but was valuable for the diagnosis of bronchial and pulmonary diseases in the mid-20th century.

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Yes, Propyliodone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200821. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4949. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.